Nanovaccine boosts immunity in sufferers of metabolic syndrome

A new class of biomaterial developed by researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria -- a population that shows resistance to traditional flu and polio vaccines.

from Health & Medicine News -- ScienceDaily https://ift.tt/2FGUJJE

Comments

Popular posts from this blog

New target to improve response to cancer immunotherapy

New 3D imaging and visualization technique provides detailed views of muscle architecture